Neogen
NEOG
$12.14
Share price
1.51%
Change (1 day)
-27.82%
Change (1 year)
Neogen (NEOG) - Total debt
Total debt on the balance sheet as of November 2023 : $0.88 B
According to Neogen's latest financial reports the company's total debt is $0.88 B. A company’s total debt is the sum of all current and non-current debts.
Neogen - Total debt on balance sheet (from 2001 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023-05-31 | $0.88 B | |
| 2006-05-31 | $9.95 M | |
| 2004-05-31 | $3.9 M | |
| 2001-05-31 | $0.07 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Thermo Fisher Scientific TMO | $34.91 B | 3,825.53% | 🇺🇸 USA |
 Becton Dickinson BDX | $16.11 B | 1,711.16% | 🇺🇸 USA |
 IDEXX Laboratories IDXX | $1.06 B | 20.00% | 🇺🇸 USA |
 Illumina ILMN | $2.26 B | 154.30% | 🇺🇸 USA |
 Danaher DHR | $19.53 B | 2,096.33% | 🇺🇸 USA |
 PerkinElmer
PKI | $4.50 B | 407.01% | 🇺🇸 USA |
 Pacific Biosciences
PACB | $0.93 B | 5.00% | 🇺🇸 USA |
 Meridian Bioscience VIVO | $30.95 M | -96.52% | 🇺🇸 USA |